Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation. (Q42635997)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

title

Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1 reference

1 reference

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

Paola Meraviglia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

Antonella Castagna

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

Hamid Hasson

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Schiavini M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

Viganò P

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

Bini T

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

Landonio S

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

Danise A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

Moioli MC

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

Angeli E

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

Bongiovanni M

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

Cargnel A

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

334-343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15369508 AND SRC:MED&resulttype=core&format=json

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

A cohort study of nevirapine tolerance in clinical practice: French Aquitaine Cohort, 1997-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Recovery of the immune system with antiretroviral therapy: the end of opportunism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Pathologic features of chronic hepatitis. A review and update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Hepatitis C and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Hepatitis C in the setting of HIV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X

Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4 T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1468-1293.2004.00232.X